This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Le Marchand, L. Articles by Donlon, T. Search for Related Content PubMed PubMed Citation Articles by Le Marchand, L. Articles by Donlon, T.

Combined Effects of Well-done Red Meat, Smoking, and Rapid N-Acetyltransferase 2 and CYP1A2 Phenotypes in Increasing Colorectal Cancer Risk¹

Etiology Program, Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii 96813

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion Appendix 1 References

 
Heterocyclic amines (HAAs) are suspected carcinogens that are formed in meat when it is cooked at high temperature for long durations. These compounds require metabolic activation by CYP1A2 and N-acetyltransferase (NAT) 2 or NAT1 before they can bind to DNA. It has been hypothesized that well-done meat increases the risk of colorectal cancer (CRC), especially in individuals with the rapid phenotype for CYP1A2 and NAT2. This association may be particularly strong in smokers because smoking is known to induce CYP1A2. We conducted a population-based case-control study on Oahu, Hawaii to specifically test this hypothesis. An in-person interview assessed the diet and preference for well-done red meat of 349 patients with CRC and 467 population controls. A urine collection after caffeine challenge and a blood collection were used to assess phenotype for CYP1A2 and NAT2 and genotype for NAT2 and NAT1, respectively. No statistically significant main effect association with CRC was found for red meat intake, preference for well-done red meat, the NAT2 rapid genotype, the CYP1A2 rapid phenotype or the NAT1*10 allele. However, in ever-smokers, preference for well-done red meat was associated with an 8.8-fold increased risk of CRC (95% confidence interval, 1.7–44.9) among subjects with the NAT2 and CYP1A2 rapid phenotypes, compared with smokers with low NAT2 and CYP1A2 activities who preferred their red meat rare or medium. No similar association was found in never-smokers, and there was no increased risk for well-done meat among smokers with a rapid phenotype for only one of these enzymes or for smokers with both rapid phenotypes who did not prefer their red meat well-done. These data provide additional support to the hypothesis that exposure to carcinogens (presumably HAAs) through consumption of well-done meat increases the risk of CRC, particularly in individuals who are genetically susceptible (as determined by a rapid phenotype for both NAT2 and CYP1A2) and suggest that smoking, by inducing CYP1A2, facilitates this effect.

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion Appendix 1 References

 
CRC³ remains the third most common malignancy in the United States, with 130,200 new cases expected in 2000 (1) . Few causative factors are known with certainty for this disease. Hereditary syndromes, such as familial adenomatous polyposis and hereditary nonpolyposis CRC, account for <10% of all cases. First-degree family history of large bowel cancer is associated with a 2-fold increased risk for the disease, after exclusion of the known familial syndromes, suggesting the existence of unidentified genetic susceptibility factors. In addition, it is suspected that overnutrition, physical inactivity, a high red meat diet, alcohol use, smoking, and a low intake of vegetables may increase CRC risk, but the data are not conclusive (2) . Possibly explaining the association with red meat is the observation that potent chemical carcinogens (e.g., heterocyclic aromatic amines and polycyclic aromatic hydrocarbons) are formed when meat is cooked at high temperature for a prolonged period of time (3) .

HAAs require N-oxidation by CYP1A2, followed by O-esterification by NAT1 or NAT2, before they can exert their genotoxicity (4 , 5) . At least 10 single-base substitution variants have been identified in the NAT2 gene, seven of which result in amino acid changes. Combinations of these substitutions result in alleles coding for decreased enzyme activity, and five these alleles (*5A, *5B, *5C, *6A, and *7B) occur with significant frequency (>1%; Ref. 6 ). CYP1A2 is also thought to be polymorphically expressed, although no genetic variant has been clearly demonstrated to explain the interindividual variation in enzyme activity. CYP1A2 is also known to be inducible by various environmental exposures including smoking (7) . It has been hypothesized that the rapid NAT2 phenotype confers an increased CRC risk, especially when combined with the rapid CYP1A2 phenotype and consumption of well-done meat (7 , 8) . Recent data have only been weakly supportive of this hypothesis (9) . This may be due to the fact that these studies did not consider CYP1A2 and grouped together rapid and intermediate acetylators, in effect "diluting" the high-risk group (10) . They also may not have considered the possible modifying effect of smoking. A variant allele for NAT1 (*10) associated with higher acetylation activity in colon tissue has also been suggested to increase CRC (11) .

Intrigued by the high frequency of the rapid acetylator phenotype in Japanese and the rapid increase in CRC incidence and the high red meat intake observed among Japanese migrants to Hawaii (12) , we conducted a population-based case-control study to test the relationships of NAT2 and NAT1 genotypes, CYP1A2 and NAT2 phenotypes (as assessed by caffeine challenge), and doneness of meat with CRC in Hawaii.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion Appendix 1 References

 
Cases were identified through the rapid reporting system of the Hawaii Tumor Registry, a member of the United States National Cancer Institute’s Surveillance, Epidemiology, and End Results program. Eligible cases consisted of all Japanese, Caucasian, or native Hawaiian Oahu residents diagnosed before the age of 85 years with a primary adenocarcinoma of the colon or rectum in the main medical centers of Oahu between January 1994 and August 1998. Controls were selected from participants in an ongoing health survey conducted by the Hawaii State Department of Health among an annual 2% random sample of the state households following a design modeled after that of the National Health Survey (13) . This source was supplemented with controls from Health Care Financing Administration participants on Oahu. One control was matched to each case on sex, ethnicity, and age (±2 years). Personal interviews were obtained from 768 matched pairs of cases and controls, resulting in a participation rate of 58.2% and 53.2% for cases and controls, respectively. The reasons for nonparticipation in cases were as follows: (a) refusal (22.5%); (b) death before contact (10.9%); (c) severe disease (6.7%); and (d) inability to locate (1.7%). The reasons for nonparticipation in controls were as follows: (a) refusal (34.8%); (b) inability to locate (9.2%); and (c) major illness or death (2.8%). Compared with noninterviewed cases, interviewed cases had the same ethnic and sex distribution but were less likely to have a regional or distant metastasis (46% versus 55%) and were younger by an average of 1.8 years. A blood sample was obtained for 548 cases (71.3% of interviewed cases) and 656 controls (85.4% of interviewed controls). A caffeine test was successfully completed on 349 of these cases (45.4% of interviewed cases) and 467 of these controls (60.8% of interviewed controls).

In-person interviews were conducted at the subjects’ homes by trained interviewers. The median interval between diagnosis and interview for cases was 4.5 months (25th–75th percentiles, 3.3–8.4 months). The questionnaire included detailed information on demographics, including the race of each grandparent; a quantitative food frequency questionnaire; a lifetime history of tobacco, alcohol, and aspirin use; a history of recreational sports activities since age 18; a personal history of various relevant medical conditions; a family history of CRC in parents and siblings; information on height and weight at different ages; and for women, a history of reproductive events and hormone use. The food frequency questionnaire has been described previously (14) and validated (15) in this population. Frequencies and amounts consumed during the reference period (the year prior to onset of symptoms for cases or interview for controls) were obtained for 268 food items or categories. Daily intake in grams for each food item was computed for each individual. A food composition nutrient database that was based primarily on the United States Department of Agriculture’s nutrient database and supplemented from other sources for ethnic-specific foods and recipes was applied to the food items to compute nutrient intakes. Food groupings were computed by summing intake from appropriate food items and relevant proportions from mixed dishes. Red meat was defined as including all beef and pork items, but not processed meat. Participants also reported their intakes and dosages of vitamin and mineral supplements during the reference period. In a separate question referring to 5 years prior to the interview, subjects were also asked whether they ate red meat and, if so, how they liked it cooked (rare, medium-rare, medium, well done, or very well done).

In preparation for the caffeine test (16) , subjects were asked to refrain from consuming foods that may induce or inhibit CYP1A2 (well-done meat, cruciferous vegetables, and grapefruit) during the 2 days prior to the test, and they were asked to refrain from consuming caffeine-containing beverages and caffeine- and acetaminophen-containing drugs during the day preceding the test (17) . Subjects were also asked to fast from 10 p.m. to the time of the blood draw the following morning. After venipuncture, the subjects drank a cup of coffee made of two packets of Maxwell House instant coffee (57 mg caffeine/packet), maintained fasting for another 2 h, voided 4 h after coffee consumption, and provided a 1 h urine specimen at the end of the fifth hour after dosing. No other source of caffeine was consumed during the 5-h period. The urine samples were acidified with ascorbate, kept on ice, and processed within 4 h of collection. The volume of urine was recorded, and the samples were stored at -70°C until analysis.

All laboratory analyses were performed blind to the case-control status of the samples. Urinary ratios of AFMU:1X and of (17U + 17X):137X were measured as described previously (10 , 16 , 17) to assess NAT and CYP1A2 activity, respectively. Each analytical batch included the same number of samples from cases and controls. The intra-assay coefficients of variation assessed by analyzing 10% blind duplicates were 4.3% for (17U+17X):137X and 10.6% for AFMU:1X. Past data from our group on intraindividual variability for both ratios suggested that one measurement performed reasonably well in characterizing long-term activity for both NAT2 and CYP1A2 (10 , 17) .

DNA was purified from blood lymphocytes, and the subjects were genotyped for NAT2 and NAT1 according to published protocols (10 , 11) . This NAT2 genotyping method identifies nucleotide substitutions C481T, G590A, and G857A, which are diagnostic for the common slow activity alleles *5A,B, *6A,B, and *7A,B. In addition, we genotyped our samples for T341C to identify the slow activity allele *5C using primers 5'-CACCTTCTCCTGCAGGTGACCG-3' and 5'-TGTCAAGCAGAAAATGCAAGGC-3'. The PCR conditions consisted of an initial denaturation at 95°C for 5 min, followed by 35 cycles of 94°C for 30 s, 58°C for 30 s, and 72°C for 30 s, with a final extension at 72°C for 10 min. Twenty-five µl of the reaction product were digested with AciI and subjected to electrophoresis on a 3.5% MetaPhor agarose gel. The T341C substitution creates an AciI recognition site that results in the digestion of the 141-bp fragment into 121 and 20 bp (18) .

Individuals were classified as "slow" acetylators when they had two low acetylation activity alleles (any two of NAT2 *5A,B, *5C, *6A,B, or *7A,B) or "intermediate" acetylators when they had one such allele. The remaining subjects were assumed to be wild type or to carry the rare C282T variant, both of which are associated with high acetylation activity, and were classified as "rapid" acetylators. Similarly, individuals who carried two or one NAT1*10 allele(s) were classified as "rapid" or "intermediate" acetylators for NAT1, respectively.

Forty-one case-control pairs were excluded because of a missing covariate on the case or control. The statistical analysis used conditional logistic regression for analyses including all of the matched interviewed case-control pairs (19) . The models were adjusted for variables found to be associated with CRC in this study, namely, pack-years of cigarette smoking, lifetime recreational physical activity, body mass index 5 years ago, lifetime use of aspirin (in months), years of schooling, and intakes of non-starch polysaccharides from vegetables and calcium from foods and supplements. Because the relationships observed were dose dependent, all of these covariates were entered as continuous variables. Models with CYP1A2 phenotype were further adjusted for number of cigarettes, cigars, or pipes smoked by the subject during the 2 weeks preceding the caffeine test because smoking is known to induce CYP1A2. Nonsmokers were given the value 0 for amount smoked. Nutrient intakes were adjusted for total caloric intake by the method of residuals (20) . The urinary metabolic ratios were log-transformed and categorized into tertiles or halves to maximize cell counts. Other continuous exposure variables were categorized according to the quantile distributions among the controls. Dose-response relations were evaluated by inclusion in the model of a trend variable assigned the median value of the appropriate quantile for quantitative exposures and the value 1, 2, or 3 for increasing number of variant alleles for genotypes. The case-control matching was broken for the analysis of the genotyping and phenotyping data because not all subjects provided biospecimens. Unconditional logistic regression was then used with further adjustment for age, sex, and ethnicity. The likelihood ratio test was used to determine interaction among certain variables with respect to CRC. The test compares a main effects, no interaction model with a fully parameterized model containing all possible interaction terms for the variables of interest.

	Results

Top Abstract Introduction Materials and Methods Results Discussion Appendix 1 References

 
Sixty percent of the subjects were Japanese, 26% were Caucasian, and 14% were Hawaiian. Table 1 compares characteristics of subjects who agreed to the caffeine test with those of all interviewed subjects by case-control status. The controls who were phenotyped were similar to all interviewed controls for virtually all of the variables examined, whereas the phenotyped cases were slightly younger, more physically active, and more likely to be male and have used aspirin regularly than all interviewed cases. Both phenotyped cases and controls ate slightly more red meat than all interviewed cases and controls. Importantly, case-control differences were conserved in the phenotyped group. Compared with controls, cases were less educated, more likely to have a first-degree relative family history of CRC, and less likely to have used aspirin regularly. Cases had smoked more cigarettes and exercised less during their lifetimes. They were also heavier and consumed more calories, less calcium, less non-starch polysaccharides from vegetables, and more processed meats than controls.

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion Appendix 1 References

 
In this case-control study, we found a 9-fold increase in CRC risk for ever-smokers who preferred their red meat well-done and had a rapid metabolic phenotype for both NAT2 and CYP1A2. Well-done red meat was not associated with risk among never-smokers or smokers with the slow or intermediate phenotype for one or both of these enzymes. The association was not explained by other known risk factors. These data suggest that exposure to carcinogens through consumption of well-done meat increases the risk of CRC only in genetically susceptible individuals, as determined by these two polymorphically expressed genes, and only in smokers. The NAT1*10 allele was not associated with risk.

A recent review of the epidemiological data on red meat intake and CRC concluded that red meat probably increases the risk of this malignancy, although it was unclear whether this association was due to animal fat, processing or cooking methods, or other factors (2) . A recent study in Hawaii also found that the association between beef intake and CRC was much stronger in subjects with a family history of the disease, suggesting a genetic component (21) . The few past studies that have specifically explored the role of cooking have found a higher risk of CRC or adenoma for well-done or heavily browned meat (22, 23, 24, 25) , although some studies have been negative (26 , 27) . Cooking of meat produces mutagens and carcinogens, such as HAAs, polycyclic aromatic amines, and possibly other agents (3) . The amount of carcinogens formed is clearly related to the temperature and duration of cooking (3 , 28) . A recent Swedish study using a detailed questionnaire to estimate intake of HAAs found no association with colon or rectal cancers, although an increased risk was suggested at the highest level of intake (29) .

The metabolic activation of HAAs is thought to occur via N-oxidation in the liver by CYP1A2, followed by O-acetylation by NAT2 or NAT1 in the liver or colon to form N-acetoxy arylamine that binds to DNA to give carcinogen-DNA adducts (4 , 5) . An association between NAT1 and CRC has been found in only one (11) of five past studies (9) . Most previous studies, however, focused on the relationship between NAT2 phenotype or genotype and CRC risk. Three of the four studies that used a pharmacological probe to assess the acetylation phenotype found a higher CRC risk among individuals with the rapid phenotype (8 , 30, 31, 32) . A recent review of past studies of NAT2 genotype and CRC or adenoma concluded that no consistent association has been found, with 10 of 11 studies showing no association with the rapid/intermediate acetylator genotype (9) . However, most studies that examined the joint effect of dietary exposure and the NAT2 phenotype or genotype found a stronger effect on CRC or adenoma risk for meat (32) , fried meat (33) , red meat (34) , or a meat mutagen index (35) in rapid/intermediate acetylators than in slow acetylators, providing some evidence for an interaction.

Lang et al. (7) further hypothesized that the individuals at greatest risk for CRC would be those who are not only exposed to HAA carcinogens and possess a rapid N-acetylation phenotype but also have a rapid N-oxidation phenotype. In their hospital-based case-control study of 75 CRC or polyp cases and 205 controls in Arkansas, they found that preference for well-done meat was associated with a 2.1-fold increased risk of CRC (95% CI, 1.0–4.1) and that the rapid-rapid NAT2/CYP1A2 phenotype was associated with a 2.9-fold increased risk of CRC (95% CI, 1.4–6.1). Consistent with their hypothesis, they also found a (nonsignificant) 6-fold increased risk of CRC for individuals with the well-done preference and the rapid-rapid NAT2/CYP1A2 phenotype compared with those with a rare/medium preference and the slow/slow phenotype (7) . The present study specifically attempted to reproduce these findings with a population-based design, larger sample size, and careful adjustment for confounders. The results that we obtained are also in agreement with the hypothesis. However, they differ somewhat from those of past studies in that they suggest that risk of CRC is increased by consuming red meat only when it is cooked well-done and only among smokers with both the rapid CYP1A2 and NAT2 phenotypes. No increased risk was observed in genetically susceptible individuals who were less likely to be exposed or preferred their meat well-done but never smoked.

As discussed elsewhere (12) , this finding is consistent with the descriptive and analytical epidemiology of CRC among Japanese migrants who came to the United States at the turn of the last century. The rates for this disease increased rapidly among this group to surpass the level of the host population, and Hawaii Japanese now have the highest reported CRC rates in the world (36 , 37) . More recently, CRC rates have been increasing in Japan (36 , 37) , presumably also as the result of the Westernization of the diet. Beef intake has been identified as an important CRC risk factor in Hawaii Japanese in two previous case-control studies (21 , 38) . Japanese were found to be more likely to prefer their red meat well done or very well done in the present study (27.5% versus 17.1% for Caucasians and 23.4% for Hawaiians). Although CYP1A2 activity does not show significant difference between Japanese and Caucasians (10) , the rapid acetylation phenotype is much more common in Japanese, possibly conferring a distinct genetic susceptibility to CRC on this population. Thus, it is tempting to speculate that this genetic susceptibility manifested itself when Japanese migrated to the United States (and in more recent years in Japan) due to an increased exposure to well-done meat carcinogens, presumably HAAs. Nevertheless, additional factors, such as low vegetable and fiber intake and overnutrition, are also likely to have contributed to the increased CRC risk of Hawaii Japanese (10) .

The strengths and limitations of the data need to be considered. The study was specifically designed to test the hypothesis, making it less likely that the association found in this study was due to chance. Also, strengthening the likelihood of a true association is the fact that the association was consistently observed across sex-, ethnic-, and subsite-specific groups and with NAT2 phenotype assessed by both genotyping and caffeine metabolism. Although it is still unclear which of the proposed ratios of caffeine metabolites assesses the CYP1A2 phenotype with the least error, the (17X + 17U):137X ratio is being used in a variety of epidemiology and biomarker studies (39) . A differential bias due to case-control differences in caffeine absorption or urine flow resulting from the disease or its treatment appears unlikely because it would have to operate more strongly among individuals with the rapid/rapid phenotype. The simple cooking preference question used to assess exposure to HAAs in this study is likely to have resulted in misclassification and attenuation of the risk estimates. Thus, the association between well-done meat and CRC may in reality be significantly stronger and may not be limited to subjects with the rapid phenotypes.

As in other recent molecular epidemiology studies, the response rates were less than optimal due to the extensive participation requested from subjects. However, we found very little indication that nonparticipants were different in any major way from the interviewed subjects or that refusal to provide a biospecimen was associated with lifestyle or genotype. It seems unlikely that a selection bias could explain the observed interaction, but this cannot be excluded. Similarly, recall bias does not seem likely to explain our findings because it would have had to occur only in rapid metabolizers. However, replication of these results is desirable, preferably with a prospective design. Additional polymorphic genes are admittedly involved in the activation and detoxification of well-done meat carcinogens. However, our failure to consider them in the present study, as well as additional rare NAT2 alleles, is more likely to have attenuated our risk estimates than to have created a spurious association.

In summary, these data provide support to the hypothesis that exposure to carcinogens (presumably HAAs) through consumption of well-done meat increases the risk of CRC in smokers with the rapid phenotype for both NAT2 and CYP1A2. Means for reducing the amount of HAAs formed in meat during cooking have been described and include marinating, precooking by microwaving, and frequently turning the meat over during cooking (40 , 41) .

	Appendix 1

Top Abstract Introduction Materials and Methods Results Discussion Appendix 1 References

	Acknowledgments

 
We thank the Hawaii Tumor Registry, Castle Medical Center, Kaiser-Permanente Medical Center, Kuakini Medical Center, Queen’s Medical Center, Straub Clinic and Hospital, St. Francis Medical Center, and Wahiawa General Hospital for collaboration. We also thank Aleli Vinoya for assistance with data analysis.

	Footnotes

 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¹ Supported in part by Grant R01-CA60987 and Contract N01-CN55424 from the National Cancer Institute, United States Department of Health and Human Services.

² To whom requests for reprints should addressed, at Etiology Program, Cancer Research Center of Hawaii, University of Hawaii, 1236 Lauhala Street, Suite 407, Honolulu, HI 96813.

³ The abbreviations used are: CRC, colorectal cancer; HAA, heterocyclic amine; NAT, N-acetyltransferase; AFMU, 5-acetylamino-6-formylamino-3-methyluracil; 17U, 1,7-dimethyluric acid; 17X, 1,7-dimethylxanthine; 1X, 1-methylxanthine; 137X, caffeine; OR, odds ratio; CI, confidence interval.

Received 5/ 4/01; revised 9/20/01; accepted 9/29/01.

	References

Top Abstract Introduction Materials and Methods Results Discussion Appendix 1 References

 

1. American Cancer Society. Cancer Facts and Figures American Cancer Society Atlanta, GA 2000.
2. World Cancer Research Fund/American Institute for Cancer Research. Food Nutrition and the Prevention of Cancer: A Global Perspective American Institute for Cancer Research Washington, D.C. 1997.
3. Sugimura T. Overview of carcinogenic heterocyclic amines. Mutat. Res., 376: 211-219, 1997.[Medline]
4. Turesky R. J., Lang N. P., Butler M. A., Teitel C. H., Kadlubar F. F. Metabolic activation of carcinogenic heterocyclic amines by human liver and colon. Carcinogenesis (Lond.), 12: 1839-1845, 1991.[Abstract/Free Full Text]
5. Hein D. W., Doll M. A., Rustan T. D., Gray K., Feng Y., Ferguson R. J., Grant D. M. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferase. Carcinogenesis (Lond.), 13: 1633-1638, 1993.[Abstract/Free Full Text]
6. Cascorbi I., Brockmoller J., Mrozikiewicz P. M., Muller A., Roots I. Arylamine N-acetyltransferase activity in man. Drug Metab. Rev., 31: 489-502, 1999.[Medline]
7. Lang N. P., Butler M. A., Massengill J., Lawson M., Stotts R. C., Hauer-Jensen M., Kadlubar F. F. Rapid metabolic phenotypes for acetyltransferase activity and cytochrome CYP1A2 and putative exposure to food-borne heterocyclic amine increase the risk of colorectal cancer or polyps. Cancer Epidemiol. Biomark. Prev., 3: 675-682, 1994.[Abstract]
8. Lang N. P., Chu D. Z., Hunter C. F., Kendall D. C., Flammang T. J., Kadlubar F. F. Role of aromatic amine acetyltransferase in human colorectal cancer. Arch. Surg., 121: 1259-1261, 1986.[Abstract]
9. Brockton N., Little J., Sharp L., Cotton S. C. N-Acetyltransferase polymorphisms and colorectal cancer: a HuGE review. Am. J. Epidemiol., 151: 846-861, 2000.[Abstract/Free Full Text]
10. Le Marchand L., Sivaraman L., Franke A. A., Custer L. J., Wilkens L. R., Lau A. F., Cooney R. V. Predictors of N-acetyltransferase activity: should caffeine phenotyping and NAT2 genotyping be used interchangeably in epidemiological studies?. Cancer Epidemiol. Biomark. Prev., 5: 449-455, 1996.[Abstract]
11. Bell D. A., Stephens E. A., Castranio T., Umbrach D. M., Watson M., Deakim M., Elder J., Hendrickse C., Duncan H., Strange R. C. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res., 55: 3537-3542, 1995.[Abstract/Free Full Text]
12. Le Marchand L. Combined influence of genetic and dietary factors on colorectal cancer incidence in Japanese Americans. Monogr. Natl. Cancer Inst., 26: 101-105, 1999.
13. Oyama, N., and Johnson, D. B. Hawaii Health Surveillance Program Survey Methods and Procedures. Research and Statistics Report No. 54. Honolulu, HI: Hawaii State Department of Health, Research and Statistics Office, 1986.
14. Le Marchand L., Wilkens L. R., Hankin J. H., Kolonel L. N., Lyu L. C. Case-control study of diet and colorectal cancer in a multiethnic population: lipids and foods of animal origin. Cancer Causes Control, 8: 637-648, 1997.[Medline]
15. Hankin J. H., Wilkens L. R., Kolonel L. N., Yoshizawa C. N. Validation of a quantitative diet history method in Hawaii. Am. J. Epidemiol., 133: 616-628, 1991.[Abstract/Free Full Text]
16. Butler M. A., Lang N. P., Young J. F., Caporaso N. E., Vineis P., Hayes R. B., Teitel C. H., Massengill J. P., Lawsen M. F., Kadlubar F. F. Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics, 2: 116-127, 1992.[Medline]
17. Le Marchand L., Franke A., Custer L., Wilkens L., Cooney R. V. Lifestyle and nutritional correlates of cytochrome P450IA2 activity: inverse association with plasma lutein and -tocopherol. Pharmacogenetics, 7: 11-19, 1997.[Medline]
18. Deitz A. C., Zheng W., Leff M. A., Gross M., Wen W-Q., Doll M. A., Xiao G. H, Folsom A. R., Hein D. W. N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women. Cancer Epidemiol. Biomark. Prev., 9: 905-910, 2000.[Abstract/Free Full Text]
19. Breslow, N. E., and Day, N. E. Statistical Methods in Cancer Research. Vol. 1. The Analysis of Case-Control Studies. IARC Scientific Publ. No. 32. Lyon, France: IARC, 1980.
20. Willett W. C., Stampfer M. J. Total energy intake: implications for epidemiologic analyses. Am. J. Epidemiol., 124: 17-27, 1986.[Free Full Text]
21. Le Marchand L., Wilkens L. R., Hankin J. H., Kolonel L. N., Lyu L-C. Independent and joint effects of family history and lifestyle on colorectal cancer risk: implications for prevention. Cancer Epidemiol. Biomark. Prev., 8: 45-51, 1999.[Abstract/Free Full Text]
22. Gehardsson de Verdier M., Hagman U., Peters R. K., Steineck G., Overvik E. Meat, cooking methods and colorectal cancer: a case-referent study in Stockholm. Int. J. Cancer, 49: 520-525, 1991.[Medline]
23. Schiffman M. H., Felton J. S. Re: Fried foods and the risk of colon cancer. Am. J. Epidemiol., 131: 376-378, 1990.[Free Full Text]
24. Probst-Hensch N. M., Sinha R., Longnecker M. P., Witte J. S., Ingles S. A., Frankl H. D., Lee E. R., Haile R. W. Meat preparation and colorectal adenomas in a large sigmoidoscopy-based case-control study in California (United States). Cancer Causes Control, 8: 175-183, 1997.[Medline]
25. Sinha R., Chow W. H., Kulldorff M., Demobile J., Butler J., Garcia-Closas M., Weil R., Hoover R. N., Rothman N. Well-done, grilled red meat increases the risk of colorectal adenomas. Cancer Res., 59: 4320-4324, 1999.[Abstract/Free Full Text]
26. Lyon J. L., Mahoney A. W. Fried foods and the risk of colon cancer. Am. J. Epidemiol., 128: 1000-1006, 1988.[Abstract/Free Full Text]
27. Muscat J. E., Wynder E. L. The consumption of well-done red meat and the risk of colorectal cancer. Am. J. Public Health, 84: 856-858, 1994.[Abstract/Free Full Text]
28. Skogg K. I., Johansson M. A. E., Jagerstad M. I. Carcinogenic heterocyclic amines in model systems and cooked foods: a review on formation, occurrence and intake. Food Chem. Toxicol., 36: 879-896, 1998.[Medline]
29. Augustsson K., Skog K., Jagerstad M., Dickman P. W., Steineck G. Dietary heterocyclic amines and cancer of the colon, rectum, bladder, and kidney: a population-based study. Lancet, 353: 703-707, 1999.[Medline]
30. Ladero J. M., Gonzales J. F., Benitez J., Vargas E., Fernadez M. J., Baki W., Diaz-Rubio M. Acetylator polymorphism in human colorectal carcinoma. Cancer Res., 51: 2098-2100, 1991.[Abstract/Free Full Text]
31. Ilett K. F., David B. M., Dechton P., Castleden W. M., Kwa R. Acetylation phenotype in colorectal carcinoma. Cancer Res., 47: 1466-1469, 1987.[Abstract/Free Full Text]
32. Roberts-Thomson I. C., Ryan P., Khoo K. K., Hart W. J., McMichael A. J., Butler R. N. Diet, acetylator phenotype and risk of colorectal neoplasia. Lancet, 347: 1372-1374, 1996.[Medline]
33. Welfare M. R., Cooper J., Bassendine M. F., Daly A. K. Relationship between acetylator status, smoking, diet and colorectal cancer risk in the north-east of England. Carcinogenesis (Lond.), 18: 1351-1354, 1997.[Abstract/Free Full Text]
34. Chen J., Stampfer M. J., Hough H. L., Garcia-Closas M., Willett C., Hennekens C. H., Kelsey K. T., Hunter D. J. A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer. Cancer Res., 58: 3307-3311, 1998.[Abstract/Free Full Text]
35. Kampman E., Slattery M. L., Bigler J., Leppert M., Samowitz W., Caan B. J., Potter J. D. Meat consumption, genetic susceptibility, and colon cancer risk: a United States Multicenter Case-control Study. Cancer Epidemiol. Biomark. Prev., 8: 15-24, 1999.[Abstract/Free Full Text]
36. Parkin, D. M., Muir, C. S., Whelan, S. L., Gao, Y. T., Ferlay, J., and Powell, J. Cancer Incidence in Five Continents, Vol. VI. Lyon, France: IARC, 1992.
37. Parkin, D. M., Whelan, S. L., Ferlay, J., Raymond, L., and Young, J. Cancer Incidence in Five Continents, Vol. VII. Lyon, France: IARC, 1997.
38. Haenszel W., Berg J. W., Segi M., Kurihara M., Locke F. B. Large bowel cancer in Hawaiian Japanese. J. Natl. Cancer Inst. (Bethesda), 51: 1765-1779, 1973.
39. Kadlubar, F. K., Young, J. F., Lang, N. P., Caporaso, N. E., Sinha, R., and Landi, M. T. Correspondence re: Letter to the editor by B. K. Tang and W. Kalow on CYP1A2 phenotyping using caffeine. Cancer Epidemiol. Biomark. Prev., 5: 231, 1996. Cancer Epidemiol. Biomark. Prev., 5: 757–758, 1996.
40. Robbana-Barnat S., Rabache M., Rialland E., Fradin J. Heterocyclic amines: occurrence and prevention in cooked food. Environ. Health Perspect., 104: 280-288, 1996.[Medline]
41. Salmon P. C., Knize M. G., Panteleakos F. N., Wu R. W., Nelson D. O., Felton J. S. Minimization of heterocyclic amines and thermal inactivation of Escherichia coli in fried ground beef. J. Natl. Cancer Inst. (Bethesda), 92: 1773-1778, 2000.[Abstract/Free Full Text]

This article has been cited by other articles:

				B. S. Saltzman, J. F. Yamamoto, R. Decker, L. Yokochi, A. G. Theriault, T. M. Vogt, and L. Le Marchand Association of Genetic Variation in the Transforming Growth Factor {beta}-1 Gene with Serum Levels and Risk of Colorectal Neoplasia Cancer Res., February 15, 2008; 68(4): 1236 - 1244. [Abstract] [Full Text] [PDF]

				L. Le Marchand and L. R. Wilkens Design Considerations for Genomic Association Studies: Importance of Gene-Environment Interactions Cancer Epidemiol. Biomarkers Prev., February 1, 2008; 17(2): 263 - 267. [Full Text] [PDF]

				S. Kury, B. Buecher, S. Robiou-du-Pont, C. Scoul, V. Sebille, H. Colman, C. Le Houerou, T. Le Neel, J. Bourdon, R. Faroux, et al. Combinations of Cytochrome P450 Gene Polymorphisms Enhancing the Risk for Sporadic Colorectal Cancer Related to Red Meat Consumption Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1460 - 1467. [Abstract] [Full Text] [PDF]

				J. Bendaly, S. Zhao, J. R. Neale, K. J. Metry, M. A. Doll, J. C. States, W. M. Pierce Jr., and D. W. Hein 2-Amino-3,8-Dimethylimidazo-[4,5-f]Quinoxaline-Induced DNA Adduct Formation and Mutagenesis in DNA Repair-Deficient Chinese Hamster Ovary Cells Expressing Human Cytochrome P4501A1 and Rapid or Slow Acetylator N-Acetyltransferase 2 Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1503 - 1509. [Abstract] [Full Text] [PDF]

				N. Nagamine, Y. Kawada, and Y. Sakakibara Identifying cooperative transcriptional regulations using protein-protein interactions Nucleic Acids Res., August 26, 2005; 33(15): 4828 - 4837. [Abstract] [Full Text] [PDF]

				M. Deguchi, S. Yoshida, S. Kennedy, N. Ohara, S. Motoyama, and T. Maruo Lack of Association Between Endometriosis and N-acetyl transferase 1 (NAT1) and 2 (NAT2) Polymorphisms in a Japanese Population Reproductive Sciences, April 1, 2005; 12(3): 208 - 213. [Abstract] [PDF]

				M. A. Murtaugh, C. Sweeney, K.-n. Ma, B. J. Caan, and M. L. Slattery The CYP1A1 Genotype May Alter the Association of Meat Consumption Patterns and Preparation with the Risk of Colorectal Cancer in Men and Women J. Nutr., February 1, 2005; 135(2): 179 - 186. [Abstract] [Full Text] [PDF]

				A. C. Deitz, N. Rothman, T. R. Rebbeck, R. B. Hayes, W.-H. Chow, W. Zheng, D. W. Hein, and M. Garcia-Closas Impact of Misclassification in Genotype-Exposure Interaction Studies: Example of N-Acetyltransferase 2 (NAT2), Smoking, and Bladder Cancer Cancer Epidemiol. Biomarkers Prev., September 1, 2004; 13(9): 1543 - 1546. [Abstract] [Full Text] [PDF]

				L. Le Marchand, A. Seifried, A. Lum-Jones, T. Donlon, and L. R. Wilkens Association of the Cyclin D1 A870G Polymorphism With Advanced Colorectal Cancer JAMA, December 3, 2003; 290(21): 2843 - 2848. [Abstract] [Full Text] [PDF]

				A. J. Fretland, U. S. Devanaboyina, M. A. Doll, S. Zhao, G. H. Xiao, and D. W. Hein Metabolic Activation of 2-Hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Syrian Hamsters Congenic at the N-Acetyltransferase 2 (NAT2) Locus Toxicol. Sci., August 1, 2003; 74(2): 253 - 259. [Abstract] [Full Text] [PDF]

				S. Kimura, M. Kawabe, A. Yu, H. Morishima, P. Fernandez-Salguero, G. J. Hammons, J. M. Ward, F. F. Kadlubar, and F. J. Gonzalez Carcinogenesis of the food mutagen PhIP in mice is independent of CYP1A2 Carcinogenesis, March 1, 2003; 24(3): 583 - 587. [Abstract] [Full Text] [PDF]

				J.H. Barrett, G. Smith, R. Waxman, N. Gooderham, T. Lightfoot, R.C. Garner, K. Augustsson, C.R. Wolf, D.T. Bishop, D. Forman, et al. Investigation of interaction between N-acetyltransferase 2 and heterocyclic amines as potential risk factors for colorectal cancer Carcinogenesis, February 1, 2003; 24(2): 275 - 282. [Abstract] [Full Text] [PDF]

				L. Le Marchand, T. Donlon, A. Seifried, and L. R. Wilkens Red Meat Intake, CYP2E1 Genetic Polymorphisms, and Colorectal Cancer Risk Cancer Epidemiol. Biomarkers Prev., October 1, 2002; 11(10): 1019 - 1024. [Abstract] [Full Text] [PDF]

				L. Le Marchand, T. Donlon, A. Seifried, R. Kaaks, S. Rinaldi, and L. R. Wilkens Association of a Common Polymorphism in the Human GH1 Gene with Colorectal Neoplasia J Natl Cancer Inst, March 20, 2002; 94(6): 454 - 460. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Le Marchand, L. Articles by Donlon, T. Search for Related Content PubMed PubMed Citation Articles by Le Marchand, L. Articles by Donlon, T.